FDA cuts hit AI division, even as Trump invests in the technology

WASHINGTON — The layoffs over the weekend at the Food and Drug Administration appear to have hit the AI and digital health staff particularly hard at a time when federal regulators are scrambling for ways to keep tabs on hospitals and insurers that are embracing the technologies.

The terminations, with their potential to halt or hobble AI regulation, have caused alarm both inside and outside the agency, according to people interviewed by STAT. Use of AI in health care has swelled over…